Search IconSearch
July 20, 2020/COVID-19

Neurologic Manifestations of COVID-19: More Common Than We Thought (Podcast)

Mechanisms range from inflammation to infection of neurons

The more cases of COVID-19 we diagnose, the more neurologic manifestations we recognize. From loss of taste and smell to stroke to Guillain-Barré-type syndromes and meningoencephalitis-like illnesses, the presentations of COVID-19 infection are as varied as their mechanisms.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Some neurologic manifestations, which previously were thought to be rare, now appear to be more common,” says Jeffrey Cohen, MD, Director of the Experimental Therapeutics Program in Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research.

In the newest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Cohen discusses the latest understanding of COVID-19’s neurologic effects. His audio interview touches on:

  • Mechanisms of neurologic involvement
  • Caring for patients with neurologic disorders, such as multiple sclerosis, during the pandemic
  • Cleveland Clinic’s multiple lines of research on COVID-19 infection

Click the player below to listen to the 16-minute podcast, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.


Excerpt from the podcast

Dr. Cohen: Stroke is turning out to be an important neurologic manifestation of COVID-19. There are two scenarios. One is in the older patient with cardiovascular comorbidities, who may develop a stroke in association with a critical COVID-19 infection. The other setting that we’re recognizing increasingly is stroke in young people. That may be due to the hypercoagulable state that the virus infection may induce, or it may be due to a vasculitis-like illness. If one encounters a stroke in a young person, COVID-19 is an important consideration.

Some neurologic manifestations of COVID-19 infection are immune-mediated. These include illnesses that look like Guillain-Barré syndrome or other acute central nervous system inflammatory demyelinating conditions. But, in some patients, there may be a direct viral infection of the central nervous system. There have been emerging cases of a meningoencephalitis-like illness. Infection of neurons in certain key areas of the brain, such as those involved with cardiopulmonary regulation, also may contribute to respiratory failure.

Other symptoms of COVID-19 include ageusia (loss of taste) and anosmia (loss of smell). These symptoms are of interest because they’re unusual and because they can occur acutely with only mild other symptoms or, in some cases, preceding other symptoms. In some patients, they may be due to inflammation of the nasal pharynx. But in other cases, it has been hypothesized that they result from direct viral infection of olfactory bulb neurons or other central nervous system neurons involved in taste and smell.

Related Articles

Stellate Ganglion Block
May 17, 2023/COVID-19
Nerve Block Shows Promise for Long COVID-Related Olfactory or Gustatory Dysfunction

Patients report improved sense of smell and taste

Covid image
April 26, 2023/COVID-19
What Long COVID Means for Rheumatologists (Video)

Clinicians who are accustomed to uncertainty can do well by patients

Covid related skin effects
April 4, 2023/COVID-19
Cutaneous Manifestations of COVID-19 in Special Populations

Unique skin changes can occur after infection or vaccine

February 10, 2023/COVID-19
Effects of COVID-19 on Blood Sugar and Type 2 Diabetes

Cleveland Clinic analysis suggests that obtaining care for the virus might reveal a previously undiagnosed condition

January 13, 2023/COVID-19
Optimal Management of High Risk Immunocompromised Patients in the COVID-19 Era

As the pandemic evolves, rheumatologists must continue to be mindful of most vulnerable patients

covid-19 virus
January 12, 2023/COVID-19
Real World Experience with Tixagevimab/Cilgavimab in B-Cell-Depleted Patients

Early results suggest positive outcomes from COVID-19 PrEP treatment

Eosinophilic Fasciitis
November 29, 2022/COVID-19
New Onset Eosinophilic Fasciitis after COVID-19 Infection

Could the virus have caused the condition or triggered previously undiagnosed disease?

COVID-19 and rash
June 16, 2022/COVID-19
Common Skin Signs of COVID-19 in Adults: An Update

Five categories of cutaneous abnormalities are associated with COVID-19